INTRODUCTION {#sec1-1}
============

In India, the health care delivery system remains largely uncontrolled with large number of private operators catering to a portion of population. With globalization, the focus of the health sector, at least of the larger set ups, is turning to standardization of protocols and projection of quality of health care. One of the tools of measurement of quality of health care is standardized mortality ratio (SMR)-ratio of observed over predicted mortality. Several models for mortality prediction have been developed to assess severity of illness and predict mortality in intensive care units (ICUs). These models are useful in assessing severity of illness, predicting mortality, standardizing research, and assessing performance of ICUs. Acute Physiology and Chronic Health Evaluation II (APACHE II) and Simplified Acute Physiology Score II (SAPS II) are two of the commonly cited models in India.\[[@ref1][@ref2]\]

Several studies have reported varying performance of these models in predicting mortality in a new population and/or different case mix. These variations in performance have been attributed to variations in the population, case mix, quality of care, quality of data, and errors in the application of scores.\[[@ref3][@ref4][@ref5][@ref6][@ref7][@ref8][@ref9]\] It is imperative, therefore, that the models be tested before their application to a different population and/or case mix.

Validation of these scores has been extensively done in Europe, USA, and Australian continent but data from the Indian subcontinent is sparse. Most Indian studies have addressed specific subgroups like respiratory, obstetric, surgical, cancer, and so on.\[[@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20]\] To our knowledge, there are no published studies on validation of these models in mixed ICUs in Maharashtra, India.

Our aim was to assess the performance and utility of these two models in predicting mortality in a single tertiary multidisciplinary ICU. The secondary objectives were benchmarking and setting a base line for research and quality improvement.

MATERIALS AND METHODS {#sec1-2}
=====================

Study design and data collection {#sec2-1}
--------------------------------

In this observational study, data were collected prospectively for all consecutive admissions to 28-bedded multidisciplinary ICU of a private 550-bedded tertiary hospital in Western Maharashtra, India in the year 2011 (from January 1 to December 31, 2011). This hospital has separate coronary care unit, neurotrauma unit and pediatric ICU. Patients with ICU length of stay of less than 24 h, age less than 18 years and discharged against medical advice were excluded from the final analysis. For patients who were admitted to the ICU more than once during the same hospital admission, data only from the first admission were included. Approval was obtained from the local ethics committee.

ICU resident doctors were given orientation sessions to ensure high quality of collected data and were also given real-time feedback on missing data and logical errors. They were requested to double check whether the tests were obtained during the first 24 h in case of physiological parameters not filled in the forms.

Demographic data, chronic health status (organ failure/immunosuppression), diagnostic category leading to ICU admission according to International Classification of Disease, 10^th^ edition (ICD-10) were noted on admission on specially designed data collection forms. Worst (most deranged) values of physiological parameters required for calculation of APACHE II and SAPS II and type of admission (medical, elective/emergency surgical) were filled in by ICU registrars after 24 h. Since axillary temperatures were routinely measured in this ICU, those were noted and core temperature was assumed to be one degree higher than axillary temperature for the purpose of calculation of scores. For sedated patients, Glasgow Coma Scale (GCS) before sedation were recorded. Principal diagnostic category leading to admission was recorded as described by Knaus *et al*.\[[@ref1]\] In case of values not recorded in the form; it was assumed that such values were within normal limits. Data were routinely cross-verified with available online laboratory reports and nursing charts including double checking missing values. Scores were calculated using online calculators for consistency.\[[@ref21][@ref22]\] Patients were followed-up to hospital discharge for their survival status. Data were entered into a computer program specifically designed for the study.

Statistical analysis {#sec2-2}
--------------------

Student\'s *t*-test was used to compare normally distributed continuous variables. Predictive models can be tested in terms of calibration and discrimination. Calibration refers to the ability of the model to accurately predict mortality. To check the degree of association between mortality patterns predicted by the models and true mortality, records were sorted according to increasing predicted probability of death and divided into 10 subgroups (deciles) with approximately same number (154) of cases. Graphs were plotted by plotting average predicted probability of death against true risk in each decile. R^2^ statistics were calculated by linear regression.

To test the predictive accuracy of the two models, the Hosmer-Lemeshow goodness-of-fit test was applied. The test statistic is obtained by applying a Chi-square test on a ×2 *g* contingency table. The contingency table is constructed by cross-classifying the dichotomous dependent variable with a grouping variable (with g groups) in which groups are formed by partitioning the predicted probabilities using the percentiles of the predicted event probability. In the calculation, approximately 10 groups are used (g = 10).\[[@ref23]\]

SMRs were calculated by dividing the observed number of deaths by the number of deaths predicted by each model. SMRs for categories as per ICD-10 classification were calculated for subgroups consisting of at least 100 admissions.

To assess discriminating ability of the models, receiver operating characteristic (ROC) curves were constructed for each model by plotting true positives (sensitivity) against false positives (1-specificity) at several decision cutoffs. Discrimination is the ability of the model to distinguish between true positives (nonsurvivors in this case) and false positives. An important advantage of ROC analysis over traditional sensitivity-specificity analysis is that the area under the ROC curve is independent both of the cut-point criteria chosen and the prevalence of outcome of interest.

To test the stability of the models, bootstrap analysis of SMR with 1000 samples of increasing number of random cases (e.g., 100 random cases, 200 random cases, and so on) was done. Comparison of patterns of true mortality and mortalities predicted by the two models was also done by bootstrap analysis using 1000 samples of 600 random cases each and probability density chart was plotted.\[[@ref24]\]

Data were represented as mean ± standard deviation (SD) and significance level of 0.05 was used wherever applicable. Epiinfo, OpenEpi, Microsoft excel, IBM SPSS, and 'R' were used for data management and analysis.\[[@ref25][@ref26][@ref27]\]

RESULTS {#sec1-3}
=======

A total of 2014 patients were admitted to the ICU in the study period. Patients with ICU stay of less than 24 h (*n* = 211), age less than 18 years (*n* = 7), discharged against medical advice (*n* = 163), incomplete data (*n* = 9), subsequent readmission to ICU (*n* = 81) were excluded from the final analysis. Hence, the data of 1543 patients were available for analysis. Total 273 (17.7%) patients died in the hospital, while the mortalities predicted by APACHE II and SAPS II were 311.6 (20.2%) and 288.5 (18.7%), respectively.

[Table 1](#T1){ref-type="table"} details demographic data and clinical categories of patients. Majority of patients (*n* = 1003, 65%) were male. Mean age of the cohort was 53.9 ± 16.8 years. Mean age (56.5 years) and mean length of ICU stay (6.3) were significantly higher in nonsurvivors than in survivors (mean age = 53.4 years, mean length of stay = 4.7). Maximum number of admissions were medical (*n* = 1235, 80%) followed by elective surgical (*n* = 231, 15%) followed by emergency surgical (*n* = 77, 5%). Mortality was highest in emergency surgical group (24.6%) and lowest in elective surgical group (5.6%). Mortality in medical patients was 19.5%. Total of 589 patients (38.1%) were admitted with chronic organ failure of which 529 patients (34.3%) had single, whereas 60 patients (3.8%) had multiple organ failure. Among patients with chronic organ failure, renal failure was most common (21.3%) followed by cardiovascular (9.7%), respiratory (5.9%), and liver insufficiency (5.1%). Mortality was highest in patients admitted with liver insufficiency (43.8%) followed by patients with respiratory failure (27.2%). Survival in patients with chronic cardiovascular and renal failure was 82.8% and 83.9%, respectively.

###### 

Demographic information and clinical categories of patients
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Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} give a quick visual assessment of strength of association between true and predicted mortality patterns. APACHE II overpredicted mortality below 0.5 probability of dying while underpredicted mortality above probability of 0.5. SAPS II overpredicted mortality above 0.2 probability. There was very strong association between true and predicted mortality by both models. R^2^ for APACHE II and SAPS II were 0.98 and 0.99, respectively.

![Comparison of average risk of death predicted by APACHE II and true risk. X-axis: Deciles of approximately 154 records each in ascending risk of death. APACHE II: Acute Physiology and Chronic Health Evaluation II; SMR: Standardized Mortality Ratio](IJCIIS-4-29-g002){#F1}

![Comparison of average risk of death predicted by SAPS II and true risk X-axis: Deciles of approximately 154 records each in ascending predicted risk of death. SAPS II: Simplified Acute Physiology Score II; SMR: Standardized Mortality Ratio](IJCIIS-4-29-g003){#F2}

Both models performed poorly in Hosmer-Lemeshow goodness of fit test. APACHE II performed slightly better with smaller Chi-square statistics (12.8) and higher significance level (*P* = 0.03) as against Chi-square of 26.6 (*P* = 0.001) of SAPS II.

SMRs using APACHE II and SAPS II were 0.88 and 0.95, respectively.

Both models showed good discrimination by ROC Curves. APACHE II model showed a slightly better discrimination \[area under the curve (AUC): 0.86 ± 0.013SE, *P* \< 0.001, 95% confidence interval (CI): 0.83-0.88\] than SAPS II (AUC: 0.83 ± 0.013 SE, *P* \< 0.001, 95% CI: 0.81-0.86). The difference was not statistically significant (*P* = 0.1).

In bootstrap analysis with increasing sample size both models demonstrated reasonable stability (SD ≤ 0.05 in SMR) only above the sample size of 600.

[Figure 3](#F3){ref-type="fig"} presents comparison of patterns of true mortality and predicted mortalities by both models using bootstrap analysis of 1000 samples of 600 random cases.

![Probability Density Chart. X-axis: No. of deaths per sample of 600 cases. For any range on the X-axis, area under the curve gives probability that any given 600 people sample will have mortality within that range. APACHE II: Acute Physiology and Chronic Health Evaluation II; SAPS II: Simplified Acute Physiology Score II. Note: For the bootstrap analysis, SMR was calculated on 1000 samples of 600 random cases each picked from the original data set. It provides an assessment of underlying distribution and behavior of the models in different random samples](IJCIIS-4-29-g004){#F3}

Mean true mortality was 106.2 ± 7.5. Mean mortality predicted by APACHE II was 121.2 ± 3.9, while SAPS II predicted 112.2 ± 4.0 deaths. SMR by bootstrap analysis were 0.88 ± 0.05 and 0.95 ± 0.06 for APACHE II and SAPS II, respectively. In general, both models seemed to overpredict mortality. SAPS II seemed better but had slightly higher variance.

The most commonly missing physiological parameters were "bilirubin level" (*n* = 687, 44%) followed by "arterial blood gas" (*n* = 611, 39.5%) in the first 24 h of ICU admission.

Details of SMRs as per ICD-10 are given in [Table 2](#T2){ref-type="table"}. There were wide variations in SMR among categories (SD 0.27 and 0.30 for APACHE II and SAPS II, respectively). Both models grossly overpredicted mortality in three subgroups viz. "Genitourinary system" (SMR using APACHE II = 0.52, SAPS II = 0.51), "Circulatory system" (APACHE II 0.57, SAPS II 0.68), and "Respiratory system" (APACHE II 0.66, SAPS II 0.7). Both models underpredicted mortality in "Neoplasms" (APACHE II 1.22, SAPS II 1.26) and "Infectious and parasitic diseases" (APACHE II 1.15, SAPS II 1.16). In "Digestive system" group APACHE II overpredicted (SMR 0.86), while SAPS II underpredicted (SMR 1.36) mortality. Mortality predicted by both models in other categories was within 0.1 SD.

###### 

Standardized mortality ratio in subgroups based on International Classification of Disease, 10^th^ edition

![](IJCIIS-4-29-g005)

DISCUSSION {#sec1-4}
==========

In this cohort, patterns of mortality predicted by both APACHE II and SAPS II demonstrated strong association with true mortality. Both models also showed good discriminating ability between survivors and nonsurvivors as shown by the ROC curves.

In boot strap analysis, both models overpredicted mortality. In the formal goodness-of-fit testing, both models performed poorly. There was also significant variation in SMRs calculated for subgroups based on ICD-10. It would be interesting to note that within most of these major subgroups, both models showed good fit by Hosmer-Lemeshow goodness of fit test, for example, "respiratory system" group: APACHE II (Chi-square = 8.256, *P* = 0.409) and SAPS II (Chi-square = 9.274, *P* = 0.320). This cohort covered the entire spectrum of diseases in the Knaus' classification except for "Dissecting thoracic/abdominal aneurysm" although in different proportions. Wide variation in SMRs of subgroups is partly explained by stability of the models only above the sample size of 600.

Similar results have been reported in many studies performed on different populations outside of India. Some studies from Europe/North America, Portugal, Greece, Saudi Arabia, South England, and Thailand reported acceptable discrimination but poor calibration.\[[@ref3][@ref4][@ref5][@ref6][@ref7][@ref8][@ref9]\] The Greek\[[@ref6]\] and the Saudi Arabian\[[@ref7]\] study, however, reported underprediction of mortality, while in this cohort both models overestimated mortality. One study from Mumbai, India\[[@ref16]\] reported underestimation of mortality and poor calibration of APACHE II in cancer patients. Two studies from North India reported underestimation, poor calibration as well as poor discrimination in respiratory ICUs.\[[@ref10][@ref19]\] The variations in the performance of the models were commonly attributed to variations in population, case mix, quality of care, quality of data, and errors in application of scores. Changing treatment modalities and other clinical and nonclinical factors not accounted for by the models may also cause the results to vary.\[[@ref1][@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8][@ref9]\]

During development of APACHE II, measurement of all 12 physiologic variables was mandatory, while SAPS II assumed missing variables to be within normal limits. In these data sets, the most commonly missing variables were bilirubin level and arterial blood gas. It is reasonable to believe that these tests were not obtained in the first 24 h of ICU admission because the treating physician expected the values to be within normal limits. Utmost care was taken during the study to ensure high quality of data. Being a single center study, however, some amount of bias due to differences in case mix, ICU policy, definitions, lead-time, and quality of care might have possibly occurred.

Lack of fit in formal testing and wide variation in SMR among different subgroups put limitations on the use of these models as tools for quantifying quality of care or comparison of performance of different units with different case mix. Moreover, the models do not provide information about whether a particular patient will die or survive.\[[@ref1][@ref2]\] Utility of these models in an individual patient is, therefore, limited. Nevertheless, the models can be useful in assessing efficacy of quality improvement measures or medical intervention in a single unit assuming confounding factors (such as case mix, etc.) remain the same.

Considering comparable performance of both models in predicting mortality, SAPS II appears more suitable for this set up due to its simplicity of use. SAPS II requires lesser number of parameters. These parameters are also more readily available, for example, ratio of partial pressure and fraction of inspired oxygen for SAPS II as against alveolar-arterial oxygen gradient for APACHE II. Subjectivity is reduced while calculating SAPS II as against APACHE II because there is no need to choose a single primary diagnosis.\[[@ref2]\] Since unique probability of death is linked to each unique SAPS II score, it can be arrived at without a statistical calculator. In case of APACHE II, probability of death is adjusted according to primary diagnosis and the APACHE II score itself is not a good indicator of severity of illness. With multicenter data collection, correction factors can be derived based on ICD-10 for SAPS II to make it suitable for local use and current treatment modalities.

Considering limited resources, especially access to computers, the older, simpler models like APACHE II and SAPS II are still relevant in developing countries like India.\[[@ref28]\] Both the models under consideration have been developed by regression analysis. Other methods can be tried to develop a suitable model, for example, decision tree. The most important predictors of mortality in the decision tree drawn from this cohort were bicarbonate and bilirubin levels, hematocrit, heart rate, and need for mechanical ventilation in the first 24 h of ICU admission. Prospective data collection of such parameters from multiple centers, therefore, holds promise of developing a model suitable for Indian ICUs.

CONCLUSION {#sec1-5}
==========

Lack of fit of data to the models and wide variation in SMRs in subgroups based on ICD-10 put a limitation on utility of these models as tools for assessing quality of care and comparing performances of different units without customization. Automation may facilitate development and application of more accurate models in the future. Till that time, efforts should be made to customize and apply SAPS II to aid quality improvement and research.
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